Transaktionen anzeigen
Gesundheitswesen

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

PanTera, an IBA and SCK CEN joint venture, aims to secure the large-scale production of actinium-225 (225Ac), which is one of the most promising alpha-emitting radioisotopes to fight cancer. The funds raised will be used primarily toward the construction of a state-of-the-art production facility in Belgium. This facility will not only enable large-scale production, it will also help fulfill PanTera’s ultimate goal to improve the accessibility of future, innovative cancer therapy based on 225Ac and theranostics.

Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

PARTEIEN

Sprechen Sie mit dem Deal Team

Cédric Michils

Managing Director
Brüssel, Belgien
Oaklins KBC Securities

Bart Delusinne

Managing Director
Brüssel, Belgien
Oaklins KBC Securities

Nicolas Lambers

Associate Director
Brüssel, Belgien
Oaklins KBC Securities

Michaël Rixhon

Associate Director
Brüssel, Belgien
Oaklins KBC Securities

Robin Bundervoet

Associate
Brüssel, Belgien
Oaklins KBC Securities

Transaktionen

Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.
Gesundheitswesen

Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.

Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.

Mehr erfahren
Pharma-Skan & Skan-Medic have been acquired by Brygge Partners
Gesundheitswesen

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

Mehr erfahren
The Canton of Solothurn had a valuation report prepared for its hospitals
Gesundheitswesen

The Canton of Solothurn had a valuation report prepared for its hospitals

The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.

Mehr erfahren